Spinal 2-chloroprocaine: A comparison with small-dose bupivacaine in volunteers

Anesthesia and Analgesia

Volumn 100, Issue 2, 2005, Pages 566-572

  Yoos, Jessica R ^a   Kopacz, Dan J ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CHLOROPROCAINE; LIDOCAINE;

ADULT; AMBULATORY SURGERY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITAL DISCHARGE; HUMAN; MALE; MOBILIZATION; NERVE BLOCK; NEUROLOGIC DISEASE; NORMAL HUMAN; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPINAL ANESTHESIA; TOURNIQUET;

ADULT; ANESTHESIA, SPINAL; ANESTHETICS, LOCAL; BUPIVACAINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; ISOMETRIC CONTRACTION; MALE; MOTOR NEURONS; MUSCLE, SKELETAL; NERVE BLOCK; PAIN MEASUREMENT; PHYSICAL STIMULATION; PROCAINE;

EID: 12844254373     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000143356.17013.A1     Document Type: Article

References (27)

1. Dexter F, Abouleish A, Epstein R, et al. Use of operating room information system data to predict the impact of reducing turn-over times on staffing costs. Anesth Analg. 2003;9:1119-26.
2. Mulroy M, Larkin K, Hodgson P, et al. A comparison of spinal, epidural, and general anesthesia for outpatient knee arthroscopy. Anesth Analg 2000;91:860-4.
3. Pollock JE. Transient neurologic symptoms: etiology, risk factors, and management. Reg Anesth Pain Med 2002;27:581-6.
4. Le Truong JJ, Girard M, Drolet P, et al. Spinal anesthesia: a comparison of procaine and lidocaine. Can J Anaesth 2001;48: 470-3.
5. Kamphuis ET, Ionescu TI, Kuipers PWG, et al. Recovery of storage and emptying functions of the urinary bladder after spinal anesthesia with lidocaine and with bupivacaine in men. Anesthesiology 1998;88:210-6.
6. Ben-David B, Solomon E, Levin H, et al. Intrathecal fentanyl with small-dose dilute bupivacaine: better anesthesia without prolonged recovery. Anesth Analg 1997;85:560-5.
7. Foldes FF, McNall PG. 2-Chloroprocaine: a new local anesthetic agent. Anesthesiology 1952;13:287-96.
8. Winnie AP, Nadar AM. Santayana's prophecy fulfilled. Reg Anesth Pain Med 2001;26:558-64.
9. Reisner LS, Hochman BN, Plumer MH. Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine. Anesth Analg 1980;59:452-4.
10. Moore DC, Spierdijk J, van Kleef JD, et al. Chloroprocaine toxicity: four additional cases. Anesth Analg 1982;61:158-9.
11. Kouri ME, Kopacz DJ. Spinal 2-chloroprocaine: a comparison with lidocaine in volunteers. Anesth Analg 2004;98:75-80.
12. Smith KN, Kopacz DJ, McDonald SB. Spinal 2-chloroprocaine: a dose-ranging study and the effect of added epinephrine. Anesth Analg 2004;98:81-8.
13. Vath JS, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added fentanyl. Anesth Analg 2004;98:89-94.
14. Warren DT, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added dextrose. Anesth Analg 2004;98:95-101.
15. Yoos JR, Kopacz DJ. Spinal 2-chloroprocaine for surgery: an initial 10-month experience. Anesth Analg 2005;100:553-8.
16. Palas T. 1% chloroprocaine for spinal anesthesia. Reg Anesth Pain Med 2003;28:A52.
17. Gupta A, Axelsson K, Thorn SE, et al. Low-dose bupivacaine plus fentanyl for spinal anesthesia during ambulatory inguinal herniorrhaphy: a comparison between 6 mg and 7.5 mg of bupivacaine. Acta Anaesthesiol Scand 2003;47:13-9.
18. Ben-David B, Levin H, Solomon E, et al. Spinal bupivacaine in ambulatory surgery: the effect of saline dilution. Anesth Analg 1996;83:716-20.
19. Na K, Kopacz D. Spinal chloroprocaine solutions: density at 37 degrees C and pH titration. Anesth Analg 2004;98:70-4.
20. Horlocker T, Wedel D. Density, specific gravity, and baricity of spinal anesthetic solutions at body temperature. Anesth Analg 1993;76:1015-8.
21. Petersen-Felix S, Zbinden AM, Fischer M, et al. Isoflurane minimum alveolar concentration decreases during anesthesia and surgery. Anesthesiology 1993;79:959-65.
22. Gissen A, Datta S, Lambert D. The chloroprocaine controversy. Reg Anesth Pain Med 1984;9:124-45.
23. Wang BC, Hillman DE, Spielholz NI, Turndorf H. Chronic neurological deficits and Nesacaine-CE: an effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite? Anesth Analg 1984;63:445-7.
24. Taniguchi M, Bollen A, Drasner K. Sodium bisulfite: scapegoat for chloroprocaine neurotoxicity? Anesthesiology 2004;100: 85-91.
25. Huffnagle SL, Norris MC, Huffnagle HJ, et al. Intrathecal hyperbaric bupivacaine dose response in postpartum tubal ligation patients. Reg Anesth Pain Med 2002;27:284-8.
26. Dobrydnjov I, Axelsson K, Thorn SE, et al. Clonidine combined with small-dose bupivacaine during spinal anesthesia for inguinal herniorrhaphy: a randomized double-blinded study. Anesth Analg 2003;96:1496-503.
27. Kararmaz A, Kaya S, Turhanoglu S, et al. Low-dose bupivacaine-fentanyl spinal anaesthesia for transurethral prostatectomy. Anaesthesia 2003;58:526-30.